A Study of Single and Repeated Doses of LY3556050 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The main purpose of this study is to conduct blood tests to measure how much LY3556050 is in the bloodstream and to determine if any age, gender, or food effects exist. The study will also evaluate the safety of LY3556050. This is a 2-part study. In Part 1, single increasing doses of LY3556050 will be given orally and participants will be confined for a 5-day period. In Part 2, multiple increasing doses of LY3556050 will be given orally and participants will be confined for a 14-day period.
Epistemonikos ID: ea2c641e6b0953bd18ab894f6ae30ff9fb40bf98
First added on: May 13, 2024